Published in Blood Weekly, November 4th, 1996
In an ex-vivo experiment where enoxaparin was added to the blood drawn from 17 healthy volunteers, Neutralase was consistently more effective in reversing enoxaparin than was protamine. Neutralase showed a dose related reversal of enoxaparin while protamine did not, suggesting a potential role for Neutralase in clinical settings where the rapid reversal of low molecular weight heparins, such as enoxaparin, is required.
The company believes that the absence of a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.